Suppr超能文献

载脂蛋白L1基因型与新发白蛋白尿及肾功能下降的种族差异

APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.

作者信息

Peralta Carmen A, Bibbins-Domingo Kirsten, Vittinghoff Eric, Lin Feng, Fornage Myriam, Kopp Jeffrey B, Winkler Cheryl A

机构信息

Department of Medicine, University of California, San Francisco, California; San Francisco VA Medical Center, San Francisco, California;

Department of Medicine, University of California, San Francisco, California;

出版信息

J Am Soc Nephrol. 2016 Mar;27(3):887-93. doi: 10.1681/ASN.2015020124. Epub 2015 Jul 15.

Abstract

Variants in the APOL1 gene are associated with kidney disease in blacks. We examined associations of APOL1 with incident albuminuria and kidney function decline among 3030 young adults with preserved GFR in the Coronary Artery Risk Development in Young Adults (CARDIA) study. eGFR by cystatin C (eGFRcys) and albumin-to-creatinine ratio were measured at scheduled examinations. Participants were white (n=1700), high-risk black (two APOL1 risk alleles, n=176), and low-risk black (zero/one risk allele, n=1154). Mean age was 35 years, mean eGFRcys was 107 ml/min per 1.73 m(2), and 13.2% of blacks had two APOL1 alleles. The incidence rate per 1000 person-years (95% confidence interval) for albuminuria over 15 years was 15.6 (10.6-22.1) for high-risk blacks, 7.8 (6.4-9.4) for low-risk blacks, and 3.9 (3.1-4.8) for whites. Compared with whites, the odds ratio (95% confidence interval) for incident albuminuria was 5.71 (3.64-8.94) for high-risk blacks and 2.32 (1.73-3.13) for low-risk blacks. Adjustment for risk factors attenuated the difference between low-risk blacks and whites (odds ratio 1.21, 95% confidence interval 0.86-1.71). After adjustment, high-risk blacks had a 0.45% faster yearly eGFRcys decline over 9.3 years compared with whites. Low-risk blacks also had a faster yearly eGFRcys decline compared with whites, but this difference was attenuated after adjustment for risk factors and socioeconomic position. In conclusion, blacks with two APOL1 risk alleles had the highest risk for albuminuria and eGFRcys decline in young adulthood, whereas disparities between low-risk blacks and whites were related to differences in traditional risk factors.

摘要

APOL1基因变异与黑人肾病相关。在年轻人冠状动脉风险发展研究(CARDIA研究)中,我们对3030名肾小球滤过率(GFR)正常的年轻人进行了研究,以探讨APOL1基因与蛋白尿发病及肾功能下降之间的关联。在定期检查时测量了基于胱抑素C的估算肾小球滤过率(eGFRcys)和白蛋白与肌酐比值。参与者包括白人(n = 1700)、高危黑人(两个APOL1风险等位基因,n = 176)和低危黑人(零/一个风险等位基因,n = 1154)。平均年龄为35岁,平均eGFRcys为每1.73平方米107毫升/分钟,13.2%的黑人有两个APOL1等位基因。15年间每1000人年蛋白尿的发病率(95%置信区间),高危黑人是15.6(10.6 - 22.1),低危黑人是7.8(6.4 - 9.4),白人为3.9(3.1 - 4.8)。与白人相比,高危黑人发生蛋白尿的比值比(95%置信区间)为5.71(3.64 - 8.94),低危黑人为2.32(1.73 - 3.13)。对风险因素进行校正后,低危黑人与白人之间的差异有所减弱(比值比1.21,95%置信区间0.86 - 1.71)。校正后,高危黑人在9.3年期间每年eGFRcys下降速度比白人快0.45%。与白人相比,低危黑人每年eGFRcys下降速度也更快,但在校正风险因素和社会经济地位后,这种差异有所减弱。总之,有两个APOL1风险等位基因的黑人在青年期发生蛋白尿和eGFRcys下降的风险最高,而低危黑人和白人之间的差异与传统风险因素的差异有关。

相似文献

1
APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
J Am Soc Nephrol. 2016 Mar;27(3):887-93. doi: 10.1681/ASN.2015020124. Epub 2015 Jul 15.
2
Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
J Am Geriatr Soc. 2021 Jan;69(1):155-163. doi: 10.1111/jgs.16797. Epub 2020 Sep 7.
3
APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.
4
Race, APOL1 Risk, and eGFR Decline in the General Population.
J Am Soc Nephrol. 2016 Sep;27(9):2842-50. doi: 10.1681/ASN.2015070763. Epub 2016 Mar 10.
5
APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.
7
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Kidney Int. 2013 Dec;84(6):1207-13. doi: 10.1038/ki.2013.173. Epub 2013 May 15.
8
Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Clin J Am Soc Nephrol. 2015 May 7;10(5):784-90. doi: 10.2215/CJN.08340814. Epub 2015 Apr 17.
9
Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD.
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1771-1777. doi: 10.2215/CJN.01180117. Epub 2017 Oct 19.

引用本文的文献

1
Socioeconomic Status and Chronic Kidney Disease Among Black and White Adults: An Analysis of 2017-2020 NHANES.
Kidney Med. 2025 Jun 16;7(8):101045. doi: 10.1016/j.xkme.2025.101045. eCollection 2025 Aug.
2
Using Large Genomic Biobanks to Generate Insights into Genetic Kidney Disease.
Semin Nephrol. 2025 Jul 11:151651. doi: 10.1016/j.semnephrol.2025.151651.
3
Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia.
Am J Hematol. 2025 Jun;100(6):1019-1028. doi: 10.1002/ajh.27678. Epub 2025 Apr 5.
4
Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studies.
Int Urol Nephrol. 2025 Mar 4. doi: 10.1007/s11255-025-04443-z.
5
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
6
Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
N Engl J Med. 2025 Jan 16;392(3):228-238. doi: 10.1056/NEJMoa2404211. Epub 2024 Oct 26.
7
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE).
Kidney Int Rep. 2024 Jun 27;9(9):2677-2684. doi: 10.1016/j.ekir.2024.06.033. eCollection 2024 Sep.
8
Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment.
Aging Dis. 2024 Jun 6;16(3):1397-1413. doi: 10.14336/AD.2024.0168.
9
High-Risk Genotypes and Kidney Disease Risk in Middle-Aged Black Adults: More Questions Than Answers.
Kidney Med. 2024 May 17;6(6):100842. doi: 10.1016/j.xkme.2024.100842. eCollection 2024 Jun.
10
Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.
Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19.

本文引用的文献

1
APOL1 kidney risk alleles: population genetics and disease associations.
Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005.
2
APOL1 risk variants, race, and progression of chronic kidney disease.
N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.
3
Race, life course socioeconomic position, racial discrimination, depressive symptoms and self-rated health.
Soc Sci Med. 2013 Nov;97:7-14. doi: 10.1016/j.socscimed.2013.07.031. Epub 2013 Aug 11.
4
APOL1 variants associate with increased risk of CKD among African Americans.
J Am Soc Nephrol. 2013 Sep;24(9):1484-91. doi: 10.1681/ASN.2013010113. Epub 2013 Jun 13.
6
Cost-effectiveness of screening for microalbuminuria among African Americans.
J Am Soc Nephrol. 2012 Dec;23(12):2035-41. doi: 10.1681/ASN.2012040347.
8
Estimating glomerular filtration rate from serum creatinine and cystatin C.
N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248.
9
Racial differences in the incidence of chronic kidney disease.
Clin J Am Soc Nephrol. 2012 Jan;7(1):101-7. doi: 10.2215/CJN.06450611. Epub 2011 Nov 10.
10
Population-based risk assessment of APOL1 on renal disease.
J Am Soc Nephrol. 2011 Nov;22(11):2098-105. doi: 10.1681/ASN.2011050519. Epub 2011 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验